Clinical Trial Update: Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating flibanserin in men receiving androgen deprivation therapy for prostate cancer. The study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Flibanserin (Flibanserin)

Snippet

Sponsor: Andrew McDonald | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING